Trial Profile
A multi-centre retrospective study assessing efficacy and safety of lenalidomide therapy in patients with resistant or relapsed multiple myeloma and in patients with stable disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 May 2016 New trial record